Geode Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $42M | Buy |
|
|||||
|
2025
Q2 | $27.9M | Sell |
|
|||||
|
2025
Q1 | $28.8M | Buy |
|
|||||
|
2024
Q4 | $23.7M | Buy |
|
|||||
|
2024
Q3 | $25.4M | Buy |
|
|||||
|
2024
Q2 | $26M | Buy |
|
|||||
|
2024
Q1 | $23.5M | Buy |
|
|||||
|
2023
Q4 | $18.2M | Buy |
|
|||||
|
2023
Q3 | $18.7M | Buy |
|
|||||
|
2023
Q2 | $14.2M | Buy |
|
|||||
|
2023
Q1 | $9.74M | Buy |
|
|||||
|
2022
Q4 | $9.63M | Buy |
|
|||||
|
2022
Q3 | $7.35M | Sell |
|
|||||
|
2022
Q2 | $6.88M | Buy |
|
|||||
|
2022
Q1 | $5.51M | Sell |
|
|||||
|
2021
Q4 | $9.38M | Buy |
|
|||||
|
2021
Q3 | $5.35M | Sell |
|
|||||
|
2021
Q2 | $6.08M | Buy |
|
|||||
|
2021
Q1 | $5.78M | Buy |
|
|||||
|
2020
Q4 | $4.08M | Sell |
|
|||||
|
2020
Q3 | $4.09M | Buy |
|
|||||
|
2020
Q2 | $4.53M | Buy |
|
|||||
|
2020
Q1 | $5.55M | Buy |
|
|||||
|
2019
Q4 | $7.7M | Buy |
|
|||||
|
2019
Q3 | $8.51M | Buy |
|
|||||
|
2019
Q2 | $9.54M | Buy |
|
|||||
|
2019
Q1 | $7.47M | Buy |
|
|||||
|
2018
Q4 | $4.39M | Buy |
|
|||||
|
2018
Q3 | $5.35M | Buy |
|
|||||
|
2018
Q2 | $5.83M | Buy |
|
|||||
|
2018
Q1 | $4.85M | Buy |
|
|||||
|
2017
Q4 | $4.96M | Buy |
|
|||||
|
2017
Q3 | $3.49M | Buy |
|
|||||
|
2017
Q2 | $3.06M | Buy |
|
|||||
|
2017
Q1 | $3.19M | Buy |
|
|||||
|
2016
Q4 | $3.73M | Buy |
|
|||||
|
2016
Q3 | $3.69M | Buy |
|
|||||
|
2016
Q2 | $3.06M | Buy |
|
|||||
|
2016
Q1 | $1.79K | Buy |
|
|||||
|
2015
Q4 | $2.38M | Buy |
|
|||||
|
2015
Q3 | $2.08M | Buy |
|
|||||
|
2015
Q2 | $3.16M | Buy |
|
|||||
|
2015
Q1 | $3.07M | Buy |
|
|||||
|
2014
Q4 | $2.63M | Buy |
|
|||||
|
2014
Q3 | $1.03M | Buy |
|
|||||
|
2014
Q2 | $1.22M | Buy |
|
|||||
|
2014
Q1 | $953K | Buy |
|
|||||
|
2013
Q4 | $601K | Buy |
|
|||||
|
2013
Q3 | $281K | Buy |
|
|||||
|
2013
Q2 | $82K | Buy |
|